Richard K. Matros - 10 Feb 2026 Form 4 Insider Report for Sabra Health Care REIT, Inc. (SBRA)

Signature
/s/ Michael Costa, as Attorney-in-Fact
Issuer symbol
SBRA
Transactions as of
10 Feb 2026
Net transactions value
$0
Form type
4
Filing time
12 Feb 2026, 20:27:56 UTC
Previous filing
12 Jan 2026
Next filing
03 Mar 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
MATROS RICHARD K Chair, CEO and President, Director C/O SABRA HEALTH CARE REIT, INC., 1781 FLIGHT WAY, TUSTIN /s/ Michael Costa, as Attorney-in-Fact 12 Feb 2026 0001184158

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SBRA Common Stock Award $0 +85,160 +10% $0.000000 915,040 10 Feb 2026 Direct F1, F2
holding SBRA Common Stock 1,857,686 10 Feb 2026 By R&A Matros Revocable Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the vesting of stock units granted under the Issuer's 2009 Performance Incentive Plan subject to a funds from operations-based stock unit ("FFO units") award granted on December 27, 2022, including 17,903 shares with respect to dividend equivalent payments calculated based on the market value of the Issuer's Common Stock on the applicable dividend date. The Compensation Committee determined on February 10, 2026 that the number of FFO units earned was 90.8% of the target. Upon this determination, the FFO units vested immediately. Each FFO unit represented a contingent right to receive one share of the Issuer's Common Stock, based on the Issuer's achievement of a funds from operations target for a performance period beginning January 1, 2025 and ending December 31, 2025. The vested units will be paid on a one-for-one basis in shares of the Issuer's Common Stock on January 4, 2027, subject to earlier payment in the event of death, disability or change of control.
F2 Consists of stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock.